MEDCX | MEDFX | MEDCX / MEDFX | |
Total Expense Ratio | 1.81 | 1.06 | 171% |
Annual Report Gross Expense Ratio | 1.82 | 1.07 | 170% |
Fund Existence | 23 years | 17 years | - |
Gain YTD | 3.920 | 4.314 | 91% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.3B | 7.3B | 100% |
Annual Yield % from dividends | 5.07 | 5.81 | 87% |
Returns for 1 year | 6.75 | 7.55 | 89% |
Returns for 3 years | 28.57 | 31.53 | 91% |
Returns for 5 years | 5.63 | 9.66 | 58% |
Returns for 10 years | 27.20 | 37.20 | 73% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VCRCX | 14.36 | 0.15 | +1.06% |
NYLI CBRE Global Infrastructure Class C | |||
TDEIX | 32.46 | -0.01 | -0.03% |
Transamerica US Growth I | |||
CMEUX | 22.21 | -0.01 | -0.05% |
Six Circles Mgd Eq Port US Uncons | |||
AUUAX | 23.94 | -0.04 | -0.17% |
AB Select US Equity A | |||
SBEMX | 10.66 | -0.05 | -0.47% |
Segall Bryant & Hamill Em Mkts Instl |